SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-004603
Filing Date
2013-08-14
Accepted
2013-08-14 17:42:26
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT immy_10q.htm 10-Q 863320
2 EXHIBIT 10.4 immy_ex104.htm EX-10.4 49811
3 EXHIBIT 32.2 immy_ex105.htm EX-10.5 107917
4 EXHIBIT 31.1 immy_ex311.htm EX-31.1 18156
5 EXHIBIT 32.1 immy_ex321.htm EX-32.1 11801
6 EXHIBIT 31.2 immy_ex312.htm EX-31.2 17579
  Complete submission text file 0001354488-13-004603.txt   5591265

Data Files

Seq Description Document Type Size
7 immy-20130630.xml EX-101.INS 510577
8 immy-20130630.xsd EX-101.SCH 40884
9 immy-20130630_cal.xml EX-101.CAL 40219
10 immy-20130630_def.xml EX-101.DEF 119729
11 immy-20130630_lab.xml EX-101.LAB 266439
12 immy-20130630_pre.xml EX-101.PRE 204109
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 131038511
SIC: 2834 Pharmaceutical Preparations